Subscribe to our newsletter to receive the latest product updates and special offers

Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

NEW: Revenue Breakdown and Options Chain

Gain deeper insights into company revenues with a detailed analysis of revenue sources.
Explore the updated Options feature, providing in-depth data, and a 3D viewing option.

Last Close
Feb 26 04:00PM ET
128.84
Dollar change
-0.61
Percentage change
-0.47
%
IndexDJIA, S&P 500 P/E974.58 EPS (ttm)0.13 Insider Own0.19% Shs Outstand2.54B Perf Week0.82%
Market Cap326.48B Forward P/E13.34 EPS next Y9.66 Insider Trans-8.64% Shs Float2.53B Perf Month7.25%
Income365.00M PEG14.46 EPS next Q2.05 Inst Own78.44% Short Float0.67% Perf Quarter26.71%
Sales60.29B P/S5.42 EPS this Y466.21% Inst Trans0.64% Short Ratio2.02 Perf Half Y17.72%
Book/sh16.27 P/B7.92 EPS next Y12.99% ROA4.31% Short Interest17.02M Perf Year16.50%
Cash/sh3.48 P/C37.05 EPS next 5Y67.41% ROE10.75% 52W Range99.14 - 130.24 Perf YTD18.18%
Dividend Est.3.26 (2.53%) P/FCF24.80 EPS past 5Y-42.70% ROI0.49% 52W High-1.07% Beta0.39
Dividend TTM2.96 (2.30%) Quick Ratio1.12 Sales past 5Y7.81% Gross Margin76.98% 52W Low29.96% ATR (14)1.71
Dividend Ex-DateMar 14, 2024 Current Ratio1.38 EPS Y/Y TTM-69.86% Oper. Margin7.84% RSI (14)73.53 Volatility1.27% 1.34%
Employees69000 Debt/Eq0.85 Sales Y/Y TTM3.10% Profit Margin0.61% Recom1.54 Target Price136.08
Option/ShortYes / Yes LT Debt/Eq0.82 EPS Q/Q-140.87% Payout2065.60% Rel Volume0.60 Prev Close129.45
Sales Surprise0.97% EPS Surprise127.65% Sales Q/Q17.16% EarningsFeb 01 BMO Avg Volume8.44M Price128.84
SMA202.46% SMA509.02% SMA20017.00% Trades Volume5,056,457 Change-0.47%
Date Action Analyst Rating Change Price Target Change
Jan-04-24Upgrade TD Cowen Market Perform → Outperform $125 → $135
Nov-09-23Initiated Deutsche Bank Buy $115
Oct-27-23Upgrade BMO Capital Markets Market Perform → Outperform $132
Oct-20-23Upgrade UBS Neutral → Buy $117 → $122
Jul-14-23Initiated HSBC Securities Hold $123
Apr-13-23Upgrade Citigroup Neutral → Buy $105 → $130
Mar-28-23Downgrade Societe Generale Buy → Hold
Mar-13-23Downgrade Wells Fargo Overweight → Equal Weight $120 → $115
Mar-06-23Initiated Jefferies Buy $125
Feb-22-23Upgrade Wolfe Research Peer Perform → Outperform $127
Today 01:19PM
Feb-23-24 05:21PM
06:20AM
05:43AM
Feb-22-24 11:22AM
06:45AM Loading…
Feb-20-24 06:45AM
Feb-18-24 04:33PM
Feb-16-24 08:30AM
03:10AM
Feb-15-24 11:37PM
08:45AM
Feb-14-24 10:00AM
Feb-13-24 02:16PM
11:45AM
Feb-12-24 07:05AM
08:44AM Loading…
Feb-11-24 08:44AM
Feb-09-24 04:32PM
01:03PM
Feb-08-24 07:00AM
Feb-07-24 12:13PM
Feb-06-24 10:49AM
Feb-05-24 05:03PM
07:01AM
07:00AM
06:33AM
06:33AM
Feb-02-24 10:50AM
Feb-01-24 11:56PM
05:28PM
04:17PM
01:20PM Loading…
01:20PM
12:09PM
10:29AM
07:29AM
07:06AM
07:04AM
06:56AM
06:55AM
06:46AM
06:41AM
06:33AM
06:30AM
06:30AM
Jan-30-24 06:24PM
09:22AM
06:52AM
Jan-29-24 08:45AM
Jan-27-24 10:00AM
Jan-26-24 06:27PM
05:45PM
12:15PM
10:00AM
Jan-25-24 12:54PM
12:11PM
10:00AM
Jan-23-24 02:44PM
Jan-22-24 11:02AM
10:33AM
Jan-20-24 09:12AM
Jan-19-24 06:58AM
06:45AM
Jan-17-24 10:47AM
Jan-16-24 05:50PM
01:10PM
Jan-15-24 08:15AM
Jan-12-24 05:30PM
05:05PM
04:47PM
Jan-10-24 06:04PM
03:02PM
07:20AM
Jan-08-24 07:48PM
04:39PM
03:39PM
11:30AM
10:11AM
08:30AM
08:00AM
07:30AM
07:15AM
07:00AM
12:33AM
Jan-05-24 03:06PM
06:45AM
Jan-04-24 07:11PM
03:59PM
03:17PM
01:21AM
Jan-03-24 01:59PM
06:45AM
Dec-29-23 08:47AM
08:36AM
Dec-28-23 08:00AM
Dec-27-23 06:59PM
Dec-26-23 09:00AM
Dec-24-23 09:00AM
Dec-22-23 09:05AM
08:00AM
Dec-21-23 09:12AM
07:05AM
Merck & Co., Inc. is a health care company, which engages in the provision of health solutions through its prescription medicines, vaccines, biologic therapies, animal health, and consumer care products. It operates through the following segments: Pharmaceutical, Animal Health, and Other. The Pharmaceutical segment includes human health pharmaceutical and vaccine products. The Animal Health segment discovers, develops, manufactures, and markets animal health products, such as pharmaceutical and vaccine products, for the prevention, treatment and control of disease in livestock, and companion animal species. The Other segment consists of sales for the non-reportable segments of healthcare services. The company was founded in 1891 and is headquartered in Kenilworth, NJ.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Davis Robert MChairman, CEO & PresidentFeb 14Option Exercise73.7385,0216,268,598433,348Feb 15 04:01 PM
Litchfield CarolineEVP & CFOFeb 14Option Exercise58.0838,2912,223,94189,199Feb 15 04:03 PM
Davis Robert MChairman, CEO & PresidentFeb 14Sale125.4085,02110,661,574348,327Feb 15 04:01 PM
Litchfield CarolineEVP & CFOFeb 14Sale125.5038,2914,805,52050,908Feb 15 04:03 PM
Davis Robert MChairman, CEO & PresidentFeb 13Option Exercise74.18150,00011,127,160498,327Feb 15 04:01 PM
Davis Robert MChairman, CEO & PresidentFeb 13Sale125.85150,00018,877,424348,327Feb 15 04:01 PM
Romanelli JosephPresident, Human Health Int?lFeb 13Sale124.891,000124,88819,569Feb 14 04:03 PM
Li Dean YExecutive VP & President, MRLFeb 09Option Exercise62.0714,702912,55360,944Feb 12 04:03 PM
Li Dean YExecutive VP & President, MRLFeb 09Sale125.5014,7021,845,08346,242Feb 12 04:03 PM
Williams David MichaelEVP,Chief Info&Digital OfficerFeb 07Sale127.571,451185,10819,812Feb 08 04:04 PM
MIZELL STEVENEVP, Chief HR OfficerFeb 02Option Exercise73.6532,9942,430,15974,313Feb 02 04:07 PM
Zachary JenniferEVP, General CounselFeb 02Option Exercise87.1019,4171,691,22178,557Feb 02 04:05 PM
Oosthuizen Johannes JacobusPresident, U.S. MarketFeb 02Option Exercise78.8020,9371,649,90642,286Feb 05 04:01 PM
MIZELL STEVENEVP, Chief HR OfficerFeb 02Sale126.6550,6946,420,34923,619Feb 02 04:07 PM
Zachary JenniferEVP, General CounselFeb 02Sale126.9749,4996,284,77929,058Feb 02 04:05 PM
Oosthuizen Johannes JacobusPresident, U.S. MarketFeb 02Sale127.1718,9592,411,11123,327Feb 05 04:01 PM
Oosthuizen Johannes JacobusPresident, U.S. MarketNov 09Sale102.382,081213,06118,191Nov 13 07:36 AM
DeLuca Richard R.EVP&Pres, Merck Animal HeallthNov 08Sale105.0343,8234,602,668111,764Nov 09 09:04 AM
Oosthuizen Johannes JacobusPresident, U.S. MarketOct 30Option Exercise102.8291594,08020,723Oct 31 11:08 AM
MIZELL STEVENEVP, Chief HR OfficerAug 14Sale109.014,250463,29222,935Aug 15 04:08 PM
Guindo ChirfiChief Marketing OfficerAug 03Option Exercise105.7036,9013,900,43638,342Aug 04 04:17 PM
MIZELL STEVENEVP, Chief HR OfficerAug 03Sale105.494,500474,70127,185Aug 04 04:06 PM
Romanelli JosephPresident, Human Health Int?lAug 02Sale107.37596,3350Aug 03 04:08 PM
Romanelli JosephPresident, Human Health Int?lAug 02Sale107.37303,22120,569Aug 03 04:08 PM
Karachun Rita ASr. VP Fince-Global ControllerMay 04Option Exercise65.2416,8241,097,55261,585May 05 04:54 PM
Oosthuizen Johannes JacobusPresident, U.S. MarketMay 04Option Exercise118.22907107,22620,207May 05 05:09 PM
Klobuchar Michael AEVP - Chief Strategy OfficerMay 04Option Exercise118.22885104,62519,476May 05 05:06 PM
LeCointe-Cephas LisaSVP Chief Ethics & Com OfficerMay 04Option Exercise118.2281396,1135,421May 05 05:01 PM
Zachary JenniferEVP, General CounselMay 04Sale117.5919,1412,250,83435,128May 05 05:13 PM
Karachun Rita ASr. VP Fince-Global ControllerMay 04Sale117.5315,8751,865,84345,710May 05 04:54 PM
MIZELL STEVENEVP, Chief HR OfficerMay 03Option Exercise75.5552,0003,928,54073,085May 05 05:19 PM
Karachun Rita ASr. VP Fince-Global ControllerMay 03Option Exercise117.8980394,66645,363May 05 04:54 PM
LeCointe-Cephas LisaSVP Chief Ethics & Com OfficerMay 03Option Exercise117.8968981,2264,844May 05 05:01 PM
MIZELL STEVENEVP, Chief HR OfficerMay 03Sale119.0153,4006,355,05631,685May 05 05:19 PM
Williams David MichaelEVP,Chief Info&Digital OfficerMay 02Option Exercise56.046,035338,20118,568May 03 04:29 PM
Williams David MichaelEVP,Chief Info&Digital OfficerMay 02Sale116.827,509877,22211,059May 03 04:29 PM
DeLuca Richard R.EVP&Pres, Merck Animal HeallthMay 01Option Exercise56.0475,4364,227,433229,929May 02 11:37 AM
Li Dean YExecutive VP & President, MRLMay 01Option Exercise115.471,062122,62920,995May 03 04:10 PM
Karachun Rita ASr. VP Fince-Global ControllerMay 01Option Exercise115.47930107,38744,879May 03 04:24 PM
Litchfield CarolineEVP & CFOMay 01Option Exercise115.4786699,99732,118May 03 04:07 PM
Oosthuizen Johannes JacobusPresident, U.S. MarketMay 01Option Exercise115.4786699,99719,727May 03 03:54 PM
Klobuchar Michael AEVP - Chief Strategy OfficerMay 01Option Exercise115.4786699,99718,901May 03 03:00 PM
LeCointe-Cephas LisaSVP Chief Ethics & Com OfficerMay 01Option Exercise115.4764374,2474,376May 03 03:11 PM
Williams David MichaelEVP,Chief Info&Digital OfficerMay 01Option Exercise115.4757766,62612,731May 03 04:29 PM
DeLuca Richard R.EVP&Pres, Merck Animal HeallthMay 01Sale116.0375,4368,752,749154,493May 02 11:37 AM
Davis Robert MChairman, CEO & PresidentApr 28Option Exercise56.04143,3298,032,157415,146Apr 28 05:15 PM
DeLuca Richard R.EVP&Pres, Merck Animal HeallthApr 28Option Exercise62.0766,1634,106,737220,656May 02 11:37 AM
Davis Robert MChairman, CEO & PresidentApr 28Sale114.93143,32916,472,845271,817Apr 28 05:15 PM
DeLuca Richard R.EVP&Pres, Merck Animal HeallthApr 28Sale115.0066,1637,608,844154,493May 02 11:37 AM
Romanelli JosephPresident, Human Health Int?lApr 26Buy113.68334120,599Jun 30 04:04 PM
Chattopadhyay SanatExe V-P & Pres. MMDApr 13Option Exercise59.02134,0557,911,405134,055Apr 14 04:34 PM
Chattopadhyay SanatExe V-P & Pres. MMDApr 13Sale115.07134,05515,425,0680Apr 14 04:34 PM
Romanelli JosephPresident, Human Health Int?lMar 24Sale104.65353,66320,596Jun 30 04:04 PM
Romanelli JosephPresident, Human Health Int?lMar 20Buy105.4713614,34420,631Jun 30 04:04 PM